Smart Labels Market for Healthcare and Pharmaceutical Industry by Type of Technology (RFID, NFC and Other Technologies), Type of Packaging (Primary Packaging and Secondary Packaging), Type of Primary Packaging (Vials, Syringes, Cartridges, Ampoules, Bottles and Blister Packs), Type of Secondary Packaging (Boxes, Cartons and Pouches) and Key Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America) - Industry Trends and Global Forecasts, 2022-2035
The smart label market is expected to reach USD 3.7 million in 2023 anticipated to grow at a CAGR of 16% during the forecast period 2022-2035.
Counterfeit pharmaceuticals make up a market valued at approximately $200 billion annually, posing serious risks with 20% having incorrect dosages and 30% lacking active ingredients. The World Health Organization's report highlights these dangers to patient safety and legitimate pharmaceutical companies' credibility. To combat this, labeling services are shifting toward smart labeling tech, an integral part of intelligent packaging. Smart labels, or tags, offer benefits like easy supply chain tracking and anti-counterfeiting measures. They're expected to save companies $0.8 - 1.5 million yearly through better inventory management. However, hurdles like high integration costs and the lack of consistent global regulations might slow down the adoption of smart labels. Efforts from groups such as GS1 standards and RAIN Alliance aim to establish universal regulations, paving the way for wider acceptance of this technology.
Report Coverage
Counterfeit pharmaceuticals make up a market valued at approximately $200 billion annually, posing serious risks with 20% having incorrect dosages and 30% lacking active ingredients. The World Health Organization's report highlights these dangers to patient safety and legitimate pharmaceutical companies' credibility. To combat this, labeling services are shifting toward smart labeling tech, an integral part of intelligent packaging. Smart labels, or tags, offer benefits like easy supply chain tracking and anti-counterfeiting measures. They're expected to save companies $0.8 - 1.5 million yearly through better inventory management. However, hurdles like high integration costs and the lack of consistent global regulations might slow down the adoption of smart labels. Efforts from groups such as GS1 standards and RAIN Alliance aim to establish universal regulations, paving the way for wider acceptance of this technology.
Report Coverage
- The report studies the smart label market based on type of technology, type of packaging, type of primary packaging, type of secondary packaging and key geographical regions
- It analyzes various factors such as drivers, restraints, opportunities, and challenges influencing market growth.
- Assessment of potential advantages and obstacles in the market, providing insights into the competitive landscape among leading market players.
- Forecasting revenue for market segments across five major regions.
- Smart labels significantly impact the healthcare sector by offering advanced capabilities in tracking and monitoring pharmaceuticals and healthcare products. They ensure product authenticity, streamline supply chains, enable patient-centric solutions, aid in clinical trial management, and support asset tracking.
- Smart labels encompass diverse technologies like RFID, Bluetooth, sensing, and IoT labels, utilized in supply chain management, asset tracking, patient-centric solutions, product authentication, clinical trials, blood bag management, and related functions.
- Challenges in adopting smart labels in healthcare and pharmaceuticals include regulatory compliance, cost implications, interoperability concerns, and data security. Industry growth is driven by factors such as prioritization of patient safety, technological advancements, efficient supply chain management, and enhanced pharmaceutical authentication.
- Companies involved in smart label development for healthcare and pharmaceuticals differ in supplier strength, service offerings based on application areas and RFID frequency bands, and portfolio diversity in technology types.
- Detailed profiles of notable companies specializing in smart labels for healthcare and pharmaceuticals, selected based on application diversity and company size, will include company overview, establishment year, employee count, headquarters location, key executives, smart label portfolios, recent developments, and future outlook.
- An exhaustive analysis of patents related to smart labels in healthcare and pharmaceuticals, considering patent type, publication year, geographic distribution, legal status, industry type, applicant profiles, and evaluation of patent value based on qualitative and quantitative aspects.
- Comprehensive scrutiny of partnerships and collaborations within the market, analyzing the nature, timing, key players involved, and regional focus during the specified period.
- A comprehensive strategic plan, utilizing thirteen strategic tools, to guide emerging players in exploring untapped market opportunities within the smart labels sector for healthcare and pharmaceutical applications.
- A detailed discussion on associated trends, key drivers, challenges, and their relative impact on the smart labels market for healthcare and pharmaceuticals, assessed under a SWOT framework. A Harvey ball analysis illustrates the relative effect of each SWOT parameter on the overall market.
- CCL Industries
- Schreiner
- Datalogic
- Tadbik
- SATO Asia Pacific
- Invengo
- Intellhydro Technology
- RFiD Discovery
- ID Tech Solutions
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines
2. EXECUTIVE SUMMARY
2.1 Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
3.2.1 Types of Smart Labels
3.2.1.1. Radio Frequency Identification Device (RFID)
3.2.1.2. Near-Field Communication (NFC)
3.2.1.3. Internet of Things (IoT)
3.2.2. Need for Smart Labels in the Healthcare Sector
3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Technology
4.2.6. Analysis by Company Size and Type of Technology
4.2.7. Analysis by Type of RFID Frequency Band
4.2.8. Analysis by Area(s) of Application
4.2.9. Analysis by Company Size and Area(s) of Application
4.2.10. Analysis by Type of Technology and Area(s) of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. CCL Industries
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Area(s) of Application
6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
6.3.1. Company Overview
6.3.2. Area(s) of Application
6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Area(s) of Application
6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
6.5.1. Company Overview
6.5.2. Area(s) of Application
6.5.3. Recent Developments and Future Outlook
6.6. SATO Asia Pacific
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Area(s) of Application
6.6.4. Recent Developments and Future Outlook
6.7. Invengo
6.7.1. Company Overview
6.7.2. Area(s) of Application
6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
6.8.1. Company Overview
6.8.2. Area(s) of Application
6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
6.9.1. Company Overview
6.9.2. Area(s) of Application
6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
6.10.1. Company Overview
6.10.2. Area(s) of Application
6.10.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Publication Year and Type of Patent
7.3.3. Analysis by CPC Code
7.3.4. Analysis by Type of Applicant
7.3.5. Analysis by Geography
7.3.6. Analysis by Emerging Focus Areas
7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Most Active Players: Analysis by Number of Partnerships
8.3.4. Regional Analysis
8.3.4.1. Local and International Agreements
8.3.4.2. Intercontinental and Intracontinental Agreements
9. BLUE OCEAN STRATEGY
9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
9.2.1 Red Ocean
9.2.2 Blue Ocean
9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
9.2.4.1. Value Innovation
9.2.4.2. Strategy Canvas
9.2.4.3. Four Action Framework
9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
9.2.4.5. Six Path Framework
9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
9.2.4.7. Three Tiers of Noncustomers
9.2.4.8. Sequence of Blue Ocean Strategy
9.2.4.9. Buyer Utility Map
9.2.4.10. The Price Corridor of the Mass
9.2.4.11. Four Hurdles to Strategy Execution
9.2.4.12. Tipping Point Leadership
9.2.4.13. Fair Process
9.3. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors
12. CONCLUDING REMARKS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines
2. EXECUTIVE SUMMARY
2.1 Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
3.2.1 Types of Smart Labels
3.2.1.1. Radio Frequency Identification Device (RFID)
3.2.1.2. Near-Field Communication (NFC)
3.2.1.3. Internet of Things (IoT)
3.2.2. Need for Smart Labels in the Healthcare Sector
3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Technology
4.2.6. Analysis by Company Size and Type of Technology
4.2.7. Analysis by Type of RFID Frequency Band
4.2.8. Analysis by Area(s) of Application
4.2.9. Analysis by Company Size and Area(s) of Application
4.2.10. Analysis by Type of Technology and Area(s) of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. CCL Industries
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Area(s) of Application
6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
6.3.1. Company Overview
6.3.2. Area(s) of Application
6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Area(s) of Application
6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
6.5.1. Company Overview
6.5.2. Area(s) of Application
6.5.3. Recent Developments and Future Outlook
6.6. SATO Asia Pacific
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Area(s) of Application
6.6.4. Recent Developments and Future Outlook
6.7. Invengo
6.7.1. Company Overview
6.7.2. Area(s) of Application
6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
6.8.1. Company Overview
6.8.2. Area(s) of Application
6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
6.9.1. Company Overview
6.9.2. Area(s) of Application
6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
6.10.1. Company Overview
6.10.2. Area(s) of Application
6.10.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Publication Year and Type of Patent
7.3.3. Analysis by CPC Code
7.3.4. Analysis by Type of Applicant
7.3.5. Analysis by Geography
7.3.6. Analysis by Emerging Focus Areas
7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Most Active Players: Analysis by Number of Partnerships
8.3.4. Regional Analysis
8.3.4.1. Local and International Agreements
8.3.4.2. Intercontinental and Intracontinental Agreements
9. BLUE OCEAN STRATEGY
9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
9.2.1 Red Ocean
9.2.2 Blue Ocean
9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
9.2.4.1. Value Innovation
9.2.4.2. Strategy Canvas
9.2.4.3. Four Action Framework
9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
9.2.4.5. Six Path Framework
9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
9.2.4.7. Three Tiers of Noncustomers
9.2.4.8. Sequence of Blue Ocean Strategy
9.2.4.9. Buyer Utility Map
9.2.4.10. The Price Corridor of the Mass
9.2.4.11. Four Hurdles to Strategy Execution
9.2.4.12. Tipping Point Leadership
9.2.4.13. Fair Process
9.3. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors
12. CONCLUDING REMARKS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
